Literature DB >> 9871575

Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat.

G Rastelli1, L Costantino.   

Abstract

This study reports a molecular dynamics (MD) investigation on the structure of aldose reductase (ALR2) complexed with the potent inhibitor tolrestat. The simulations predict four different orientations of tolrestat into the ALR2 binding site; these orientations have in common a strong interaction of the anionic carboxylate with Tyr48, His110, Trp111 and NADP+, but completely differ for the orientation of the aromatic portion of the inhibitor. Interestingly, the orientation in which tolrestat gives the most attractive interaction energy with the enzyme is in full accord with the x-ray crystal structure of the complex that has been reported in the literature after this work was completed. In addition, the suggestion of more than one orientation of tolrestat during MD is in agreement with recent electrospray mass spectrometry experiments on the ALR2-tolrestat complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871575     DOI: 10.1016/s0960-894x(98)00083-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations.

Authors:  V M Gokhale; V M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2000-07       Impact factor: 3.686

2.  Design, Synthesis, and In Silico Multitarget Pharmacological Simulations of Acid Bioisosteres with a Validated In Vivo Antihyperglycemic Effect.

Authors:  Elix Alberto Domínguez-Mendoza; Yelzyn Galván-Ciprés; Josué Martínez-Miranda; Cristian Miranda-González; Blanca Colín-Lozano; Emanuel Hernández-Núñez; Gloria I Hernández-Bolio; Oscar Palomino-Hernández; Gabriel Navarrete-Vazquez
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.